Steven M. Dean
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Steven M. Dean has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Amy Compston
Division of Physical Therapy, Department of Physical Medicine and Rehabilitation, James Cancer Hospital, The Ohio State University, Columbus, Ohio
1 shared publicationAnthony Vander Horst
1 shared publication- Benjamin Harris Kaffenberger
Department of Dermatology The Ohio State University Wexner Medical Center Columbus Ohio USA
1 shared publication - Bryan C. Lee
Ohio State University College of Medicine, Columbus, OH, USA
1 shared publication Elizabeth Valenti
Division of Cardiovascular Medicine, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio
1 shared publication- Eri Fukaya
Division of Vascular Surgery, Stanford University School of Medicine, Palo Alto, CA, USA
1 shared publication
Latest Publications
- 13 March 2025
- Published by SAGE Publications in Vascular Medicine
- Vol. 30 (2) , 218-237
Venous leg ulcers: A review of clinical variability and differential diagnosis
Venous hypertension due to anatomical venous insufficiency (superficial or deep venous valvular reflux and venous obstruction) and/or functional venous insufficiency (calf dysfunction, dependent edema, lymphatic dysfunction, elevated central venous pressures, etc.) leads to chronic venous insufficiency (CVI) and its sequelae. The most severe clinical manifestation of CVI is venous leg ulcer (VLU), which leads to substantial morbidity and disability. VLUs can present in both typical and atypical forms. However, several other types of leg ulcers can mimic VLUs. Therefore, vascular and wound care specialists must recognize the variability in VLU presentation and understand the differential diagnoses to deliver an accurate diagnosis and optimal care of atypical VLUs and conditions that resemble VLUs. Herein, we review and discuss the broad differential diagnosis of VLUs, supported by illustrative examples.
- 13 March 2025
- Published by SAGE Publications in Vascular Medicine
- Vol. 30 (2) , 218-237
Venous leg ulcers: A review of clinical variability and differential diagnosis
Venous hypertension due to anatomical venous insufficiency (superficial or deep venous valvular reflux and venous obstruction) and/or functional venous insufficiency (calf dysfunction, dependent edema, lymphatic dysfunction, elevated central venous pressures, etc.) leads to chronic venous insufficiency (CVI) and its sequelae. The most severe clinical manifestation of CVI is venous leg ulcer (VLU), which leads to substantial morbidity and disability. VLUs can present in both typical and atypical forms. However, several other types of leg ulcers can mimic VLUs. Therefore, vascular and wound care specialists must recognize the variability in VLU presentation and understand the differential diagnoses to deliver an accurate diagnosis and optimal care of atypical VLUs and conditions that resemble VLUs. Herein, we review and discuss the broad differential diagnosis of VLUs, supported by illustrative examples.
- 16 December 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (3) , 352-353
Images in Vascular Medicine: Madelung disease – A rare fat deposition disorder
- 16 December 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (3) , 352-353
Images in Vascular Medicine: Madelung disease – A rare fat deposition disorder
- Open Access
- 12 September 2023
- Published by MDPI AG in Hematology Reports
- Vol. 15 (3) , 518-523
Thrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
Avatrombopag is a novel oral non-peptide thrombopoietin receptor agonist (TPO-RA) that was approved by the FDA as a second-line therapy for chronic immune thrombocytopenia (cITP). Avatrombopag has shown promising results in regards to efficacy and tolerability, but to our knowledge, there are no reports of thrombotic complications associated with avatrombopag. We present two patients with chronic ITP who suffered thromboembolic events shortly after starting treatment with avatrombopag. The first case is that of a 30-year-old female with refractory cITP who failed multiple lines of ITP therapy and was hospitalized with an intracranial bleed. The patient eventually recovered after an emergent splenectomy but subsequently developed a right lower lobe pulmonary embolism three weeks after starting treatment with avatrombopag. The second case is that of a 58-year-old female with a prolonged history of ITP, and no prior history of peripheral vascular disease, who suffered from both arterial and venous thrombotic events four weeks after starting avatrombopag. Given the new arterial and venous thrombotic complications, avatrombopag was stopped. She was challenged with avatrombopag again and developed yet another thrombotic complication.
- 12 September 2023
- Published by MDPI AG in Hematology Reports
- Vol. 15 (3) , 518-523
Open AccessThrombotic Complications in Immune Thrombocytopenia Patients Treated with Avatrombopag
Avatrombopag is a novel oral non-peptide thrombopoietin receptor agonist (TPO-RA) that was approved by the FDA as a second-line therapy for chronic immune thrombocytopenia (cITP). Avatrombopag has shown promising results in regards to efficacy and tolerability, but to our knowledge, there are no reports of thrombotic complications associated with avatrombopag. We present two patients with chronic ITP who suffered thromboembolic events shortly after starting treatment with avatrombopag. The first case is that of a 30-year-old female with refractory cITP who failed multiple lines of ITP therapy and was hospitalized with an intracranial bleed. The patient eventually recovered after an emergent splenectomy but subsequently developed a right lower lobe pulmonary embolism three weeks after starting treatment with avatrombopag. The second case is that of a 58-year-old female with a prolonged history of ITP, and no prior history of peripheral vascular disease, who suffered from both arterial and venous thrombotic events four weeks after starting avatrombopag. Given the new arterial and venous thrombotic complications, avatrombopag was stopped. She was challenged with avatrombopag again and developed yet another thrombotic complication.
- 14 August 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (1) , 93-94
Images in Vascular Medicine: A strange case of painful lower-extremity lymphedema, skin thickening, and clubbing related to adenocarcinoma of the lung
- 14 August 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 29 (1) , 93-94
Images in Vascular Medicine: A strange case of painful lower-extremity lymphedema, skin thickening, and clubbing related to adenocarcinoma of the lung
- Open Access
- 1 September 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (5) , 851-859
The clinical characteristics of lower extremity lymphedema in 440 patients
- 1 September 2020
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 8 (5) , 851-859
Open AccessThe clinical characteristics of lower extremity lymphedema in 440 patients
- 7 March 2020
- Published by SAGE Publications in Vascular Medicine
- Vol. 25 (3) , 281-282
Rumpel–Leede phenomenon in a patient with chronic lymphocytic leukemia treated with acalabrutinib
- 7 March 2020
- Published by SAGE Publications in Vascular Medicine
- Vol. 25 (3) , 281-282
Rumpel–Leede phenomenon in a patient with chronic lymphocytic leukemia treated with acalabrutinib
- 4 December 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 25 (1) , 92
A curious cause of bilateral upper extremity lymphedema: ‘Puffy hand syndrome’
- 4 December 2019
- Published by SAGE Publications in Vascular Medicine
- Vol. 25 (1) , 92
A curious cause of bilateral upper extremity lymphedema: ‘Puffy hand syndrome’
- 28 November 2018
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (1) , 89-90
Servelle–Martorell syndrome
- 28 November 2018
- Published by SAGE Publications in Vascular Medicine
- Vol. 24 (1) , 89-90
Servelle–Martorell syndrome
- 1 March 2018
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 60 (6) , 567-579
Cutaneous Manifestations of Chronic Vascular Disease
- 1 March 2018
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 60 (6) , 567-579
Cutaneous Manifestations of Chronic Vascular Disease
- 6 September 2017
- Published by SAGE Publications in Vascular Medicine
- Vol. 22 (6) , 544
Kaposi sarcoma: An unconventional cause of lower extremity lymphedema
- 6 September 2017
- Published by SAGE Publications in Vascular Medicine
- Vol. 22 (6) , 544
Kaposi sarcoma: An unconventional cause of lower extremity lymphedema